VivoSeq
Other

Visceral Pain

0

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

Visceral Pain is an early-stage landscape with 0 programs across 1 company. The most active players are gicare Pharma Inc..

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

G

gicare Pharma Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

6

clinical trials

Completed4 · 67%
Unknown status1 · 17%
Recruiting1 · 17%

Clinical Trials

Trial Activity

6 trials

Effect of TEAS Combined With Oxycodone on Postoperative Visceral Pain in Gynecologic Laparoscopic Patients
Recruiting·YYangzhou University·N/A·NCT06517069·120 enrolled
Visceral Pain From the Upper Urinary Tract - a Trial on the Effect of Morphine and Oxycodone in Patients Undergoing PCNL
Completed·—·Phase 3·NCT00784472·55 enrolled
Effect of Butorphanol on Colonoscopy for Patients With Postoperative Visceral Pain
Completed·—·Phase 4·NCT04477733·203 enrolled
Lubiprostone Effects on Visceral Pain Sensitivity
Completed·UUniversity of North Carolina, Chapel Hill·Phase 1·NCT01166789·62 enrolled
Study on Analgesia of GIC-1001 & GIC-1002 on Visceral Pain, Rectal Sensory Threshold Using the Barostat Method
Completed·Ggicare Pharma Inc.·Phase 1·NCT02276768·90 enrolled
Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics
Unknown status·GGustave Roussy, Cancer Campus, Grand Paris·Phase 3·NCT00181012·100 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)